Literature DB >> 35790236

HIF-PHIs for Anemia Management in CKD: Potential and Uncertainty ASCEND.

Wendy McCallum1, Daniel E Weiner2.   

Abstract

Entities:  

Keywords:  HIF-PHI; anemia; chronic kidney disease; dialysis; erythropoiesis stimulating agent

Mesh：

Substances：

Year:  2022        PMID： 35790236      PMCID： PMC9435979          DOI： 10.2215/CJN.02440222

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   10.614


× No keyword cloud information.
  11 in total

1.  Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group.

Authors: 
Journal:  BMJ       Date:  1990-03-03

2.  Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis.

Authors:  Kai-Uwe Eckardt; Rajiv Agarwal; Ahmad Aswad; Ahmed Awad; Geoffrey A Block; Marcelo R Bacci; Youssef M K Farag; Steven Fishbane; Harold Hubert; Alan Jardine; Zeeshan Khawaja; Mark J Koury; Bradley J Maroni; Kunihiro Matsushita; Peter A McCullough; Eldrin F Lewis; Wenli Luo; Patrick S Parfrey; Pablo Pergola; Mark J Sarnak; Bruce Spinowitz; James Tumlin; Dennis L Vargo; Kimberly A Walters; Wolfgang C Winkelmayer; Janet Wittes; Rafal Zwiech; Glenn M Chertow
Journal:  N Engl J Med       Date:  2021-04-29       Impact factor: 91.245

3.  Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD.

Authors:  Glenn M Chertow; Pablo E Pergola; Youssef M K Farag; Rajiv Agarwal; Susan Arnold; Gabriel Bako; Geoffrey A Block; Steven Burke; Fausto P Castillo; Alan G Jardine; Zeeshan Khawaja; Mark J Koury; Eldrin F Lewis; Tim Lin; Wenli Luo; Bradley J Maroni; Kunihiro Matsushita; Peter A McCullough; Patrick S Parfrey; Prabir Roy-Chaudhury; Mark J Sarnak; Amit Sharma; Bruce Spinowitz; Carol Tseng; James Tumlin; Dennis L Vargo; Kimberly A Walters; Wolfgang C Winkelmayer; Janet Wittes; Kai-Uwe Eckardt
Journal:  N Engl J Med       Date:  2021-04-29       Impact factor: 91.245

4.  Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.

Authors:  Ajay K Singh; Kevin Carroll; John J V McMurray; Scott Solomon; Vivekanand Jha; Kirsten L Johansen; Renato D Lopes; Iain C Macdougall; Gregorio T Obrador; Sushrut S Waikar; Christoph Wanner; David C Wheeler; Andrzej Więcek; Allison Blackorby; Borut Cizman; Alexander R Cobitz; Rich Davies; Tara L DiMino; Lata Kler; Amy M Meadowcroft; Lin Taft; Vlado Perkovic
Journal:  N Engl J Med       Date:  2021-11-05       Impact factor: 91.245

5.  Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.

Authors:  Ajay K Singh; Kevin Carroll; Vlado Perkovic; Scott Solomon; Vivekanand Jha; Kirsten L Johansen; Renato D Lopes; Iain C Macdougall; Gregorio T Obrador; Sushrut S Waikar; Christoph Wanner; David C Wheeler; Andrzej Więcek; Allison Blackorby; Borut Cizman; Alexander R Cobitz; Rich Davies; Jo Dole; Lata Kler; Amy M Meadowcroft; Xinyi Zhu; John J V McMurray
Journal:  N Engl J Med       Date:  2021-11-05       Impact factor: 91.245

6.  A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

Authors:  Marc A Pfeffer; Emmanuel A Burdmann; Chao-Yin Chen; Mark E Cooper; Dick de Zeeuw; Kai-Uwe Eckardt; Jan M Feyzi; Peter Ivanovich; Reshma Kewalramani; Andrew S Levey; Eldrin F Lewis; Janet B McGill; John J V McMurray; Patrick Parfrey; Hans-Henrik Parving; Giuseppe Remuzzi; Ajay K Singh; Scott D Solomon; Robert Toto
Journal:  N Engl J Med       Date:  2009-10-30       Impact factor: 91.245

Review 7.  Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data.

Authors:  Julia Bohlius; Kurt Schmidlin; Corinne Brillant; Guido Schwarzer; Sven Trelle; Jerome Seidenfeld; Marcel Zwahlen; Mike J Clarke; Olaf Weingart; Sabine Kluge; Margaret Piper; Maryann Napoli; Dirk Rades; David Steensma; Benjamin Djulbegovic; Martin F Fey; Isabelle Ray-Coquard; Volker Moebus; Gillian Thomas; Michael Untch; Martin Schumacher; Matthias Egger; Andreas Engert
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

8.  Roxadustat for anemia in patients with end-stage renal disease incident to dialysis.

Authors:  Robert Provenzano; Evgeny Shutov; Liubov Eremeeva; Svitlana Korneyeva; Lona Poole; Gopal Saha; Charles Bradley; Meraf Eyassu; Anatole Besarab; Robert Leong; Cameron S Liu; Thomas B Neff; Lynda Szczech; Kin-Hung P Yu
Journal:  Nephrol Dial Transplant       Date:  2021-08-27       Impact factor: 5.992

9.  Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis.

Authors:  Robert Provenzano; Steven Fishbane; Lynda Szczech; Robert Leong; Khalil G Saikali; Ming Zhong; Tyson T Lee; Mark T Houser; Lars Frison; John Houghton; Dustin J Little; Kin-Hung Peony Yu; Thomas B Neff
Journal:  Kidney Int Rep       Date:  2020-12-24

10.  Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non-Dialysis-Dependent CKD: Pooled Results of Three Randomized Clinical Trials.

Authors:  Robert Provenzano; Lynda Szczech; Robert Leong; Khalil G Saikali; Ming Zhong; Tyson T Lee; Dustin J Little; Mark T Houser; Lars Frison; John Houghton; Thomas B Neff
Journal:  Clin J Am Soc Nephrol       Date:  2021-08       Impact factor: 10.614
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.